David Pacitti - Mar 26, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Silas Newcomb, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Mar 26, 2024
Transactions value $
$0
Form type
4
Date filed
3/28/2024, 09:00 PM
Previous filing
Apr 4, 2023
Next filing
Jun 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +10K +460.83% $0.00 12.2K Mar 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +34.6K $0.00 34.6K Mar 26, 2024 Common Stock 34.6K $5.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on March 26, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 2,000 RSUs vest on June 20, 2024 (the "Vesting Date") and (2) the remaining 8,000 RSUs vest in three equal, annual installments beginning on the first anniversary of the Vesting Date, subject to the Reporting Person's continuous service through such dates.
F2 The stock options shall vest as follows: (1) 7,302 stock options shall vest on the Vesting Date and (2) the remaining 27,331 stock options shall vest in three equal, annual installments beginning on the first anniversary of the Vesting Date, subject to the Reporting Person's continuous service through such date.